187 related articles for article (PubMed ID: 34681812)
21. Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Shao S; Ju M; Lei J; Lu X; Li H; Wang D; Xia C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165179
[TBL] [Abstract][Full Text] [Related]
22. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis.
Li L; Ameri AH; Wang S; Jansson KH; Casey OM; Yang Q; Beshiri ML; Fang L; Lake RG; Agarwal S; Alilin AN; Xu W; Yin J; Kelly K
Oncogene; 2019 Aug; 38(35):6241-6255. PubMed ID: 31312026
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15.
Kong J; Sun W; Zhu W; Liu C; Zhang H; Wang H
J Surg Oncol; 2018 Dec; 118(8):1326-1334. PubMed ID: 30332510
[TBL] [Abstract][Full Text] [Related]
24. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
27. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.
Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z
Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981
[TBL] [Abstract][Full Text] [Related]
28. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
29. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
31. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
[TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion.
Griner SE; Joshi JP; Nahta R
Biochem Pharmacol; 2013 Jan; 85(1):46-58. PubMed ID: 23085437
[TBL] [Abstract][Full Text] [Related]
34. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
35. CDP138 silencing inhibits TGF-β/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer.
Lu Y; Ma J; Li Y; Huang J; Zhang S; Yin Z; Ren J; Huang K; Wu G; Yang K; Xu S
Cell Death Dis; 2017 Sep; 8(9):e3036. PubMed ID: 28880265
[TBL] [Abstract][Full Text] [Related]
36. MCP1-Induced Epithelial-Mesenchymal Transition in Head and Neck Cancer by AKT Activation.
Lee CC; Ho HC; Su YC; Lee MS; Hung SK; Lin CH
Anticancer Res; 2015 Jun; 35(6):3299-306. PubMed ID: 26026089
[TBL] [Abstract][Full Text] [Related]
37. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
38. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
[TBL] [Abstract][Full Text] [Related]
39. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
40. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
